A behavioral economic perspective on smoking persistence in serious mental illness

Preventive Medicine

Volumn 92, Issue , 2016, Pages 31-35

  Tidey, Jennifer W ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Behavioral economics; Cigarette smoking; Comorbidity; Depression; Schizophrenia; Socioeconomic status; Tobacco control; Tobacco dependence

Indexed keywords

VARENICLINE;

ANHEDONIA; ARTICLE; BEHAVIORAL ECONOMICS; CONTINGENCY MANAGEMENT; COST; COST BENEFIT ANALYSIS; CRAVING; DEPRESSION; HUMAN; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REWARD; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING REGULATION; SOCIOECONOMICS; TOBACCO DEPENDENCE; ECONOMICS; MENTAL PATIENT; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

DEPRESSION; ECONOMICS, BEHAVIORAL; MENTAL DISORDERS; MENTALLY ILL PERSONS; NEW ENGLAND; SCHIZOPHRENIA; SMOKING;

EID: 84970016432     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.05.015     Document Type: Article

References (51)

1. Ahnallen CG, Liverant GI, Gregor KL, Kamholz BW, Levitt JJ, Gulliver SB, Pizzagalli DA, Koneru VK, Kaplan GB. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Res. 2012 Mar 30;196(1):9–14. doi: http://dx.doi.org/10.1016/j.psychres.2011.09.011.
2. Audrain-McGovern J, Rodriguez D, Leventhal AM, Cuevas J, Rodgers K, Sass J. Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation. Nicotine Tob Res. 2012 Oct;14(10):1187–96.
3. Audrain-McGovern J, Rodriguez D, Rodgers K, Cuevas J. Declining alternative reinforcers link depression to young adult smoking. Addiction 2011 Jan;106(1):178–87. doi: http://dx.doi.org/10.1111/j.1360-0443.2010.03113.x.
4. Audrain-McGovern, J., Wileyto, E.P., Ashare, R., Cuevas, J., Strasser, A.A., Reward and affective regulation in depression-prone smokers. Biol Psychiatry. 76:9 (2014 Nov 1), 689–697, 10.1016/j.biopsych.2014.04.018.
5. Benowitz NL, Henningfield JE. Reducing the nicotine content to make cigarettes less addictive. Tob. Control. 2013 May;22 Suppl 1:i14–7. doi: http://dx.doi.org/10.1136/tobaccocontrol-2012-050860.
6. Berg SA, Sentir AM, Cooley BS, Engleman EA, Chambers RA. Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions. Addict. Biol. 2014 Nov;19(6):1020–31. doi: http://dx.doi.org/10.1111/adb.12082.
7. Bickel, W.K., DeGrandpre, R.J., Higgins, S.T., Hughes, J.R., Badger, G.J., Effects of simulated employment and recreation on drug taking: A behavioral economic analysis. Exp. Clin. Psychopharmacol. 3:4 (1995 Nov), 467–476, 10.1037/1064-1297.3.4.467.
8. Bickel, W.K., Johnson, M.W., Koffarnus, M.N., MacKillop, J., Murphy, J.G., The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu. Rev. Clin. Psychol. 10 (2014), 641–677, 10.1146/annurev-clinpsy-032813-153724.
9. Brody AL Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol. Psychiatry 2009 Nov 1;66(9):898–901. doi: http://dx.doi.org/10.1016/j.biopsych.2009.06.011.
10. Brunzell DH, McIntosh JM. Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology 2012 Apr;37(5):1134–43. doi: http://dx.doi.org/10.1038/npp.2011.299.
11. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, Remington G, Gatley J. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J. Psychiatr. Res. 2014 Jan;48(1):102–10. doi: http://dx.doi.org/10.1016/j.jpsychires.2013.09.014.
12. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol. Psychiatry 2001 Jul 15;50(2):71–83.
13. Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology. 2006 Mar;184(3–4):353–66.
14. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. J. Am. Med. Assoc. 2014 Jan 8;311(2):172–82. doi: http://dx.doi.org/10.1001/jama.2013.284985.
15. Dallery J, Raiff BR, Grabinski MJ. Internet-based contingency management to promote smoking cessation: a randomized controlled study. J. Appl. Behav. Anal. 2013 Dec;46(4):750–64. doi: http://dx.doi.org/10.1002/jaba.89.
16. Daniel S, Stanton CM, Epstein LH. The future is now: reducing impulsivity and energy intake using episodic future thinking. Psychol. Sci. 2013 Nov 1;24(11):2339–42. doi: http://dx.doi.org/10.1177/0956797613488780.
17. Davies TL, Gompels M, Johnston S, Bovill B, May MT. Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals—a clinical cohort study. BMJ Open. 2013 Oct 25;3(10):e003245. doi: http://dx.doi.org/10.1136/bmjopen-2013-003245.
18. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005 Jul 15;76(2–3):135–57.
19. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, Clements LA, Sved AF. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology. 2003 Aug;169(1):68–76.
20. Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK. Randomized trial of reduced-nicotine standards for cigarettes. N. Engl. J. Med. 2015 Oct;373(14):1340–9. doi: http://dx.doi.org/10.1056/NEJMsa1502403.
21. Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015 Mar–Apr;23(2):90–8. doi: http://dx.doi.org/10.1097/HRP.0000000000000063.
22. Goelz PM, Audrain-McGovern JE, Hitsman B, Leone FT, Veluz-Wilkins A, Jepson C, Wileyto EP, D'Avanzo PA, Rivera JG, Schnoll RA. The association between changes in alternative reinforcers and short-term smoking cessation. Drug Alcohol Depend. 2014 May 1;138:67–74. doi: http://dx.doi.org/10.1016/j.drugalcdep.2014.02.007.
23. Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol. Psychiatry 2013 Sep 15;74(6):436–43. doi: http://dx.doi.org/10.1016/j.biopsych.2013.03.017.
24. Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives. A substance abuse treatment innovation. Addict. Behav. 2002 Nov–Dec;27(6):887–910.
25. Hursh, S.R., Raslear, T.G., Shurtleff, D., Bauman, R., Simmons, L., A cost–benefit analysis of demand for food. J. Exp. Anal. Behav. 50 (1988), 419–440.
26. Institute of Medicine, Ending the tobacco problem: a blueprint for the nation. 2007, Institute of Medicine of the National Academies, Washington D.C.
27. Kelly, D.L., McMahon, R.P., Wehring, H.J., Liu, F., Mackowick, K.M., Boggs, D.L., Warren, K.R., Feldman, S., Shim, J.C., Love, R.C., Dixon, L., Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 37:4 (2011 Jul), 832–838, 10.1093/schbul/sbp152.
28. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. J. Am. Med. Assoc. 2000 Nov;284(20):2606–10. doi: http://dx.doi.org/10.1001/jama.284.20.2606.
29. Leventhal AM, Trujillo M, Ameringer KJ, Tidey JW, Sussman S, Kahler CW. Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers. J. Abnorm. Psychol. 2014 May;123(2):375–86. doi: http://dx.doi.org/10.1037/a0036384.
30. Levin ME, Weaver MT, Palmatier MI, Caggiula AR, Sved AF, Donny EC. Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine. Nicotine Tob Res. 2012 Mar;14(3):299–305. doi: http://dx.doi.org/10.1093/ntr/ntr213.
31. Lopez AA, Skelly JM, Higgins ST. Financial incentives for smoking cessation among depression-prone pregnant and newly postpartum women: effects on smoking abstinence and depression ratings. Nicotine Tob Res. 2015 Apr;17(4):455–62. doi: http://dx.doi.org/10.1093/ntr/ntu193.
32. MacKillop J, Tidey JW. Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study. Psychopharmacology. 2011 Jul;216(1):91–9. doi: http://dx.doi.org/10.1007/s00213-011-2185-8.
33. McClave AK, McKnight-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am. J. Public Health 2010 Dec;100(12):2464–72. doi: http://dx.doi.org/10.2105/AJPH.2009.188136.
34. Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol. Pharmacol. 2006 Sep;70(3):801–5.
35. Morris JF, Temple W. Spirometric “lung age” estimation for motivating smoking cessation. Prev. Med. 1985 Sep;14(5):655–62.
36. Pratt, L.A., Brody, D.J., Depression and Smoking in the U.S. Household Population aged 20 and over, 2005–2008 NCHS Data Brief, no 34. 2010, National Center for Health Statistics, Hyattsville, MD.
37. Smith TT, Cassidy RN, Tidey JW, Luo X, Le CT, Hatsukami DK, Donny EC (2015, October). Impact of Smoking Reduced Nicotine Content Cigarettes on Sensitivity to Cigarette Price: Results from a Multi-Site Clinical Trial. Presented at the Annual NIH Tobacco Regulatory Science Conference, Bethesda, MD.
38. Spring, B., Pingitore, R., McChargue, D.E., Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry 160:2 (2003 Feb), 316–322 http://dx.doi.org.revproxy.brown.edu/10.1176/appi.ajp.160.2.316.
39. Swalve N, Pittenger ST, Bevins RA, Li M. Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats. Psychopharmacology. 2015 Aug;232(16):2877–87.doi: http://dx.doi.org/10.1007/s00213-015-3923-0.
40. Tidey JW. Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness. Prev. Med. 2012 Nov;55 Suppl:S54–60. doi: http://dx.doi.org/10.1016/j.ypmed.2011.11.010.
41. Tidey JW, Colby SM, Xavier EM. Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia. Nicotine Tob Res. 2014 Mar;16(3):326–34. doi: http://dx.doi.org/10.1093/ntr/ntt152.
42. Tidey JW, Higgins ST, Bickel WK, Steingard S. Effects of response requirement and the availability of an alternative reinforcer on cigarette smoking by schizophrenics. Psychopharmacology. 1999 Jul;145(1):52–60.
43. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ 2015 Sep 21;351:h4065. doi: http://dx.doi.org/10.1136/bmj.h4065.
44. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2013 Jan;15(1):121–9. doi: http://dx.doi.org/10.1093/ntr/nts098.
45. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 2011 Sep;217(2):279–87. doi: http://dx.doi.org/10.1007/s00213-011-2282-8.
46. Tidey, J.W., Rohsenow, D.J., Kaplan, G.B., Swift, R.M., Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend. 80:2 (2005), 259–265.
47. Tidey JW, Rohsenow DJ. Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls. Schizophr. Res. 2009 Dec;115(2–3):310–6. doi: http://dx.doi.org/10.1016/j.schres.2009.09.032.
48. Watson D, Naragon-Gainey K. On the specificity of positive emotional dysfunction in psychopathology: evidence from the mood and anxiety disorders and schizophrenia/schizotypy. Clin. Psychol. Rev. 2010 Nov;30(7):839–48. doi: http://dx.doi.org/10.1016/j.cpr.2009.11.002.
49. Weinberger, A.H., George, T.P., McKee, S.A., Differences in smoking expectancies in smokers with and without a history of major depression. Addict. Behav. 36:4 (2011), 434–437.
50. Williams, J.M., Gandhi, K.K., Lu, S.E., Kumar, S., Steinberg, M.L., Cottler, B., et al. Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug Alcohol Depend. 118:2–3 (2011), 313–319.
51. Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J., et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 10:12 (2008), 1691–1715, 10.1080/14622200802443569.